Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3874641 | The Journal of Urology | 2007 | 6 Pages |
Abstract
Hypoxia inducible pathway markers continue to be over expressed in sarcomatoid clear cell renal cell carcinoma, and can be of diagnostic usefulness in such high grade tumors. Over expression of vascular endothelial growth factor in the clear and nonclear cell groups raises the possibility that vascular endothelial growth factor targeted therapies may have a role in the management of sarcomatoid renal cell carcinoma, and deserve further investigation.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Satish K. Tickoo, Darym Alden, Semra Olgac, Samson W. Fine, Paul Russo, Gnanamba V. Kondagunta, Robert J. Motzer, Victor E. Reuter,